Evidence map›Paper›PMID 38958468›Full record

ArticleBlood2024

Efficacy of T-cell assays for the diagnosis of primary defects in cytotoxic lymphocyte exocytosis.

Samuel C C Chiang, Laura E Covill, Bianca Tesi, Tessa M Campbell, Heinrich Schlums, Jelve Nejati-Zendegani, Karina Mördrup, Stephanie Wood, Jakob Theorell, Takuya Sekine and 21 more

Abstract read
In one paragraph

Article in Blood, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

31 authors.

Samuel C C ChiangDepartment of Medicine, Center for Hematology and Regenerative Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden.ORCID 0000-0001-6597-6117
Laura E CovillDepartment of Medicine, Center for Hematology and Regenerative Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden.
Bianca TesiDepartment of Medicine, Center for Hematology and Regenerative Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden.
Tessa M CampbellDepartment of Medicine, Center for Hematology and Regenerative Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden.ORCID 0000-0002-7737-2123
Heinrich SchlumsDepartment of Medicine, Center for Hematology and Regenerative Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden.ORCID 0000-0002-2895-7766
Jelve Nejati-ZendeganiDepartment of Medicine, Center for Hematology and Regenerative Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden.
Karina MördrupUnit of Pediatric Rheumatology, Department of Women's and Children's Health, Karolinska Institutet, Karolinska University Hospital Solna, Karolinska Institutet, Stockholm, Sweden.ORCID 0009-0000-4652-9688
Stephanie WoodDepartment of Medicine, Center for Infectious Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden.ORCID 0000-0003-4224-759X
Jakob TheorellDepartment of Medicine, Center for Infectious Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden.ORCID 0000-0001-8752-3151
Takuya SekineDepartment of Medicine, Center for Infectious Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden.
Waleed Al-HerzDepartment of Pediatrics, Faculty of Medicine, Kuwait University, Kuwait City, Kuwait.ORCID 0000-0003-4244-4489
Himmet Haluk AkarDepartment of Pediatric Immunology, Faculty of Medicine, Erciyes University, Kayseri, Turkey.
Fatma Burcu BelenDepartment of Pediatrics, Baskent University Medical Faculty, Ankara, Turkey.
Mei Yoke ChanHaematology/Oncology Service, Department of Paediatric Subspecialties, Kandang Kerbau Women's and Children's Hospital, Singapore, Singapore.
Omer DeveciogluDepartment of Pediatric Hematology-Oncology, Istanbul Medical School, Istanbul, Turkey.ORCID 0000-0001-6378-0516
Tekin AksuDivision of Pediatric Hematology, Hacettepe University, Ankara, Turkey.ORCID 0000-0003-4968-109X
Marianne IfversenDepartment of Pediatrics and Adolescent Medicine, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.ORCID 0000-0002-2558-1935
Iwona MalinowskaDepartment of Pediatrics, Hematology and Oncology, Medical University of Warsaw, Warsaw, Poland.
Magnus SabelDepartment of Pediatrics, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.ORCID 0000-0002-3072-657X
Ekrem UnalFaculty of Health Sciences, Medical Point Hospital, Hasan Kalyoncu University, Gaziantep, Turkey.ORCID 0000-0002-2691-4826
Sule UnalDivision of Pediatric Hematology, Hacettepe University, Ankara, Turkey.
Wendy J IntroneNational Human Genome Research Institute, National Institutes of Health, Bethesda, MD.
Konrad KrzewskiReceptor Cell Biology Section, Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD.
Kimberly C GilmourImmunology, NIHR Great Ormond Street Hospital Biomedical Research Centre, London, United Kingdom.ORCID 0000-0003-0285-3958
Stephan EhlInstitute for Immunodeficiency, Center for Chronic Immunodeficiency, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.ORCID 0000-0002-9265-2721
Hans-Gustaf LjunggrenDepartment of Medicine, Center for Infectious Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden.
Magnus NordenskjöldDepartment of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0002-4974-425X
AnnaCarin HorneChildhood Cancer Research Unit, Department of Women's and Children's Health, Karolinska Institutet, Karolinska University Hospital Solna, Stockholm, Sweden.ORCID 0000-0002-2878-4463
Jan-Inge HenterChildhood Cancer Research Unit, Department of Women's and Children's Health, Karolinska Institutet, Karolinska University Hospital Solna, Stockholm, Sweden.ORCID 0000-0002-0629-2126
Marie MeethsDepartment of Medicine, Center for Hematology and Regenerative Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden.
Yenan T BrycesonDepartment of Medicine, Center for Hematology and Regenerative Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden.

Funding

Human Biochemical GeneticsZIAHG000215 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI GAHL, WILLIAM · 2009 to 2025
$72.6M
6 · The paper itself

Abstract

abstractPrimary hemophagocytic lymphohistiocytosis (HLH) is a life-threatening disorder associated with autosomal recessive variants in genes required for perforin-mediated lymphocyte cytotoxicity. A rapid diagnosis is crucial for successful treatment. Although defective cytotoxic T lymphocyte (CTL) function causes pathogenesis, quantification of natural killer (NK)-cell exocytosis triggered by K562 target cells currently represents a standard diagnostic procedure for primary HLH. We have prospectively evaluated different lymphocyte exocytosis assays in 213 patients referred for evaluation for suspected HLH and related hyperinflammatory syndromes. A total of 138 patients received a molecular diagnosis consistent with primary HLH. Assessment of Fc receptor-triggered NK-cell and T-cell receptor (TCR)-triggered CTL exocytosis displayed higher sensitivity and improved specificity for the diagnosis of primary HLH than routine K562 cell-based assays, with these assays combined providing a sensitivity of 100% and specificity of 98.3%. By comparison, NK-cell exocytosis after K562 target cell stimulation displayed a higher interindividual variability, in part explained by differences in NK-cell differentiation or large functional reductions after shipment. We thus recommend combined analysis of TCR-triggered CTL and Fc receptor-triggered NK-cell exocytosis for the diagnosis of patients with suspected familial HLH or atypical manifestations of congenital defects in lymphocyte exocytosis.

Indexed as

ExocytosisKiller Cells, NaturalLymphohistiocytosis, HemophagocyticT-Lymphocytes, CytotoxicAdolescentAdultAgedChildChild, PreschoolFemaleHumansInfantK562 CellsMaleMiddle AgedProspective StudiesReceptors, Antigen, T-Cell

Identifiers

PMID38958468
PMCPMC11375501

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.